Bosh sahifaGMAB • CPH
add
Genmab
Yopilish kursi
1 394,00 kr
Kunlik diapazon
1 398,50 kr - 1 417,00 kr
Yillik diapazon
1 398,50 kr - 2 171,00 kr
Bozor kapitalizatsiyasi
92,26 mlrd DKK
Oʻrtacha hajm
112,60 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
CPH
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (DKK) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 5,54 mlrd | 17,57% |
Joriy xarajat | 3,15 mlrd | 6,78% |
Sof foyda | 1,27 mlrd | -39,83% |
Sof foyda marjasi | 22,85 | -48,82% |
Har bir ulushga tushum | 0,29 | -38,43% |
EBITDA | 2,20 mlrd | 26,09% |
Amaldagi soliq stavkasi | 26,35% | — |
Balans
Jami aktivlari
Jami passivlari
| (DKK) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 17,32 mlrd | -37,08% |
Jami aktivlari | 39,66 mlrd | 12,55% |
Jami passivlari | 7,74 mlrd | 87,54% |
Umumiy kapital | 31,92 mlrd | — |
Tarqatilgan aksiyalar | 63,51 mln | — |
Narxi/balansdagi bahosi | 2,77 | — |
Aktivlardan daromad | 13,53% | — |
Kapitaldan daromad | 16,33% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (DKK) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 1,27 mlrd | -39,83% |
Operatsiyalardan naqd pul | 2,03 mlrd | -0,20% |
Sarmoyadan naqd pul | 224,00 mln | -77,78% |
Moliyadan naqd pul | -276,00 mln | -1 480,00% |
Naqd pulning sof oʻzgarishi | 2,01 mlrd | -40,84% |
Boʻsh pul | 1,42 mlrd | 9,09% |
Haqida
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, the Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, and Genmab K.K. in Tokyo, Japan. Genmab is a dual-listed company with shares traded on both the Copenhagen Stock Exchange in Denmark and the NASDAQ Global Select Market in the US. Wikipedia
Tashkil etilgan
1999
Sayt
Xodimlar soni
2 635
